Katharina E. Meijboom

South Parks Road
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivo.

Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivo.

Journal: Gene therapy
Published: September 19, 2022

Approaches to Gene Modulation Therapy for ALS.

Approaches to Gene Modulation Therapy for ALS.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: July 23, 2022

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.

Journal: Skeletal muscle
Published: September 13, 2021

Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy.

Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy.

Journal: JCI insight
Published: March 09, 2021

CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.

CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.

Journal: Nature communications
Published: February 08, 2021

Dystrophin involvement in peripheral circadian SRF signalling.

Dystrophin involvement in peripheral circadian SRF signalling.

Journal: Life science alliance
Published: January 07, 2021

Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice.

Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice.

Journal: Human molecular genetics
Published: May 31, 2018

Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice.

Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice.

Journal: EBioMedicine
Published: March 03, 2018

Splice-Switching Therapy for Spinal Muscular Atrophy.

Splice-Switching Therapy for Spinal Muscular Atrophy.

Journal: Genes
Published: April 21, 2017

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 14, 2016

Reducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive Motivation.

Reducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive Motivation.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: December 02, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026